Talon Therapeutics Submits New Drug Application for Marqibo

Talon Therapeutics announced its new drug application for Marqibo (vincristine sulfate liposomes injection) was submitted to the U.S. Food and Drug Administration seeking accelerated approval of Marqibo in adult Philadelphia chromosome negative acute lymphoblastic leukemia.
IEWY News